Skip to main content
Nabla logo

Nabla

A deep look at Nabla's finances, team, and market position in the AI Healthcare space.

πŸ‡«πŸ‡·FranceSeries CAI Healthcare
Updated Mar 23, 2026

Out of 100

πŸ‡«πŸ‡·

HQ

France

πŸ—“

Founded

2018

πŸ’°

Raised

$131M

🏷️

Stage

Series C

πŸ‘₯

Team

80

$180M

Post-money

$131M

All rounds

73/100

2018

80 employees

πŸ’΅Est. Annual Revenue
$20M–$100M estimated ARR

Awaira estimate based on public data. Not financial advice.

Nabla is a French AI health company founded in 2018 that develops artificial intelligence solutions for clinical documentation and patient care workflows. The company has raised $30M in total funding and operates at Series B stage with a valuation of $200M. Nabla's core offering focuses on AI-powered clinical documentation tools designed to reduce administrative burden on healthcare providers.…

Is this your company? Claim it β†’

Strengths

βœ“

Strong Awaira Score of 73/100

βœ“

Late-stage with proven business model

Analysis based on publicly available data. Not investment advice.

Nabla is a well-funded AI startup in the AI Healthcare sector. Founded in 2018, the company is currently at the Series C stage with a team of approximately 80 employees. With $131M in total disclosed funding, Nabla has demonstrated the ability to attract institutional capital. The company competes with 3 other tracked AI Healthcare companies on Awaira, including Butterfly Network and Tempus.

Awaira Score

73/100

Valuation

$180M

Total Funding

$131M

Founded

2018

Employees

80

Stage

Series C

With $131M in disclosed funding, Nabla is a well-capitalized player in the AI Healthcare segment.

Among 3 tracked competitors, Nabla ranks #4 by valuation β€” a metric investors and analysts use to gauge market standing.

Tracking Nabla on Awaira provides real-time updates on funding rounds, investor activity, and competitive moves in the AI Healthcare market.

Metricβ˜…NablaButterfly NetworkTempusAlan
Awaira Score73/10085/10084/10083/100
Total Raised$131M$370M$1.05B$750M
Valuation$180M$957M$8.1B$5.83B
StageSeries CPublicPublicSeries D
Founded2018201120152016
Employees80500-10002500500-1000
CountryπŸ‡«πŸ‡·πŸ‡ΊπŸ‡ΈπŸ‡ΊπŸ‡ΈπŸ‡«πŸ‡·
A

Alexandre Lebrun

Founder & CEO

View founder profile β†’
StageSeries C
Employees80
CountryπŸ‡«πŸ‡· France
Connect
Inactive
1 round
SeedLatest

Undisclosed

Jan 2018

Frequently Asked Questions

What is Nabla's valuation?β–Ύ
As of its latest round, Nabla carries a valuation of $180M.
Who invested in Nabla?β–Ύ
No confirmed investors have been publicly linked to this company yet. This section will be updated when new data surfaces.
When did Nabla last raise funding?β–Ύ
Capital was most recently raised through a Seed in January 2018.
How many employees does Nabla have?β–Ύ
The team is roughly 80 people, headquartered in France.
What does Nabla do?β–Ύ
Nabla is a French AI health company founded in 2018 that develops artificial intelligence solutions for clinical documentation and patient care workflows. The company has raised $30M in total funding and operates at Series B stage with a valuation of $200M. Founded in 2018, Nabla is categorized under AI Healthcare.
Who founded Nabla?β–Ύ
Behind the company is Alexandre Lebrun, who got it off the ground in 2018 in France. Alexandre Lebrun serves as Founder & CEO.
Is Nabla profitable?β–Ύ
There's no public reporting on profitability. With raised $131M in total funding, the company remains at the Series C stage.
Where is Nabla headquartered?β–Ύ
Based in France πŸ‡«πŸ‡·, the company runs its operations in the AI Healthcare space and was established in 2018.